BIDU vs LYEL · rev $18.46B vs rev $6.0K
Baidu Inc (BIDU) versus Lyell Immunopharma Inc (LYEL) — a side-by-side from cached financials, not a winner call.
Baidu Inc (BIDU) is a internet content & information company listed on US.
Lyell Immunopharma Inc (LYEL) is a biotechnology company listed on US.
Latest reported BIDU revenue for 2025-12-31 was $18.46B. Net income was $799.0M. Revenue was up 1.2% from 2024-12-31 to 2025-12-31. BIDU currently screens at market cap $37.98B.
Latest reported LYEL revenue for 2026-06-30 was $6.0K. Net income was -$68.9M. LYEL currently screens at market cap $143.5M.
BIDU currently screens at market cap $37.98B. LYEL currently screens at market cap $143.5M.
Not investment advice. Open the BIDU and LYEL stock pages for the full models.
Not investment advice.